At $2.98 a share, a director buys 8,000 Anixa Biosciences (ANIX) shares.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Anixa Biosciences director Lewis H. Titterton Jr. purchased 8,000 shares of common stock at $2.98 per share on October 23, 2026, increasing his direct holdings to 1,054,003 shares. No Rule 10b5-1 plan was reported in connection with this transaction. The SEC filing indicates the transaction was accepted by EDGAR on October 26, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.